CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 215 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,537 | +25.7% | 93,148 | +2.7% | 0.01% | +20.0% |
| Q2 2023 | $2,018 | -7.6% | 90,660 | -10.2% | 0.01% | 0.0% |
| Q1 2023 | $2,184 | -14.2% | 100,941 | -19.4% | 0.01% | -28.6% |
| Q4 2022 | $2,546 | -99.9% | 125,207 | +17.4% | 0.01% | -12.5% |
| Q3 2022 | $2,733,000 | +21.4% | 106,683 | +12.6% | 0.01% | +33.3% |
| Q2 2022 | $2,252,000 | +18.3% | 94,711 | +15.1% | 0.01% | +50.0% |
| Q1 2022 | $1,903,000 | +17.0% | 82,268 | +0.1% | 0.00% | +33.3% |
| Q4 2021 | $1,627,000 | -11.2% | 82,150 | -11.0% | 0.00% | -25.0% |
| Q3 2021 | $1,832,000 | -7.9% | 92,325 | +2.1% | 0.00% | -20.0% |
| Q2 2021 | $1,990,000 | -7.4% | 90,429 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $2,150,000 | -19.7% | 90,429 | -11.7% | 0.01% | 0.0% |
| Q4 2020 | $2,677,000 | +33.4% | 102,368 | -11.3% | 0.01% | +25.0% |
| Q3 2020 | $2,007,000 | -6.7% | 115,381 | -9.7% | 0.00% | -20.0% |
| Q2 2020 | $2,150,000 | +32.7% | 127,764 | -6.4% | 0.01% | +25.0% |
| Q1 2020 | $1,620,000 | +5.5% | 136,513 | +6.7% | 0.00% | +33.3% |
| Q4 2019 | $1,535,000 | -1.2% | 127,885 | -8.3% | 0.00% | -25.0% |
| Q2 2019 | $1,554,000 | -5.0% | 139,501 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $1,636,000 | -4.9% | 139,501 | 0.0% | 0.00% | -20.0% |
| Q4 2018 | $1,720,000 | -3.5% | 139,501 | +9.7% | 0.01% | +25.0% |
| Q3 2018 | $1,782,000 | -7.7% | 127,166 | +3.6% | 0.00% | -20.0% |
| Q2 2018 | $1,930,000 | -4.4% | 122,753 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $2,018,000 | -5.3% | 122,753 | +4.0% | 0.01% | 0.0% |
| Q4 2017 | $2,130,000 | +1379.2% | 118,054 | +1450.9% | 0.01% | – |
| Q3 2017 | $144,000 | +60.0% | 7,612 | 0.0% | 0.00% | – |
| Q2 2017 | $90,000 | +8.4% | 7,612 | 0.0% | 0.00% | – |
| Q1 2017 | $83,000 | +50.9% | 7,612 | 0.0% | 0.00% | – |
| Q4 2016 | $55,000 | -74.3% | 7,612 | -77.0% | 0.00% | – |
| Q3 2016 | $214,000 | +137.8% | 33,024 | +100.0% | 0.00% | – |
| Q2 2016 | $90,000 | – | 16,512 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
| INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
| GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
| Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
| Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
| FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
| MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
| Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |